• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Using sufficient direction factor model to analyze latent activities associated with breast cancer survival.使用充分方向因子模型分析与乳腺癌生存相关的潜在活动。
Biometrics. 2020 Dec;76(4):1340-1350. doi: 10.1111/biom.13208. Epub 2020 Jan 6.
2
Predicting censored survival data based on the interactions between meta-dimensional omics data in breast cancer.基于乳腺癌元维度组学数据间的相互作用预测删失生存数据。
J Biomed Inform. 2015 Aug;56:220-8. doi: 10.1016/j.jbi.2015.05.019. Epub 2015 Jun 3.
3
An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.整合互补的基因表达分析策略,揭示乳腺癌的新治疗机会。
Breast Cancer Res. 2009;11(4):R55. doi: 10.1186/bcr2344. Epub 2009 Jul 28.
4
Sparse multivariate factor analysis regression models and its applications to integrative genomics analysis.稀疏多变量因子分析回归模型及其在整合基因组学分析中的应用。
Genet Epidemiol. 2017 Jan;41(1):70-80. doi: 10.1002/gepi.22018. Epub 2016 Nov 10.
5
Identifying gene pathways associated with cancer characteristics via sparse statistical methods.通过稀疏统计方法识别与癌症特征相关的基因途径。
IEEE/ACM Trans Comput Biol Bioinform. 2012 Jul-Aug;9(4):966-72. doi: 10.1109/TCBB.2012.48.
6
Sparse partial least-squares regression for high-throughput survival data analysis.用于高通量生存数据分析的稀疏偏最小二乘回归
Stat Med. 2013 Dec 30;32(30):5340-52. doi: 10.1002/sim.5975. Epub 2013 Sep 18.
7
Semiparametric Bayesian kernel survival model for evaluating pathway effects.半参数贝叶斯核生存模型用于评估途径效应。
Stat Methods Med Res. 2019 Oct-Nov;28(10-11):3301-3317. doi: 10.1177/0962280218797360. Epub 2018 Oct 5.
8
Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.用于癌症生存预测的通路结构预测模型:一种两阶段方法。
Genetics. 2017 Jan;205(1):89-100. doi: 10.1534/genetics.116.189191. Epub 2016 Nov 9.
9
Analysis of tumor environmental response and oncogenic pathway activation identifies distinct basal and luminal features in HER2-related breast tumor subtypes.分析肿瘤环境反应和致癌途径激活可识别 HER2 相关乳腺癌亚型中的不同基底和腔特征。
Breast Cancer Res. 2011 Jun 7;13(3):R62. doi: 10.1186/bcr2899.
10
High-Dimensional Sparse Factor Modeling: Applications in Gene Expression Genomics.高维稀疏因子建模:在基因表达基因组学中的应用
J Am Stat Assoc. 2008 Dec 1;103(484):1438-1456. doi: 10.1198/016214508000000869.

引用本文的文献

1
Multi-omics Integrative Analysis for Incomplete Data Using Weighted -Value Adjustment Approaches.使用加权值调整方法对不完整数据进行多组学综合分析。
J Agric Biol Environ Stat. 2025;30(3):601-617. doi: 10.1007/s13253-024-00603-3. Epub 2024 Feb 28.

本文引用的文献

1
Sufficient direction factor model and its application to gene expression quantitative trait loci discovery.充分方向因子模型及其在基因表达数量性状位点发现中的应用。
Biometrika. 2019 Jun;106(2):417-432. doi: 10.1093/biomet/asz010. Epub 2019 Apr 22.
2
The Ribosome Biogenesis-Cancer Connection.核糖体生物发生与癌症的关联。
Cells. 2019 Jan 15;8(1):55. doi: 10.3390/cells8010055.
3
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis.乳腺癌的发生与进展:风险因素、癌症干细胞、信号通路、基因组学及分子发病机制
Genes Dis. 2018 May 12;5(2):77-106. doi: 10.1016/j.gendis.2018.05.001. eCollection 2018 Jun.
4
Fatty acid metabolism in breast cancer subtypes.乳腺癌亚型中的脂肪酸代谢
Oncotarget. 2017 Apr 25;8(17):29487-29500. doi: 10.18632/oncotarget.15494.
5
Identifying the crosstalk of dysfunctional pathways mediated by lncRNAs in breast cancer subtypes.识别lncRNAs在乳腺癌亚型中介导的功能失调通路的串扰。
Mol Biosyst. 2016 Mar;12(3):711-20. doi: 10.1039/c5mb00700c.
6
Identification of collaboration patterns of dysfunctional pathways in breast cancer.乳腺癌中功能失调通路协作模式的识别
Int J Clin Exp Pathol. 2014 Jun 15;7(7):3853-64. eCollection 2014.
7
Breast cancer statistics, 2013.乳腺癌统计数据,2013 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):52-62. doi: 10.3322/caac.21203. Epub 2013 Oct 1.
8
The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.致癌基因 HER2/neu(ERBB2)需要缺氧诱导因子 HIF-1 促进乳腺肿瘤生长和抗失巢凋亡。
J Biol Chem. 2013 May 31;288(22):15865-77. doi: 10.1074/jbc.M112.426999. Epub 2013 Apr 12.
9
Comprehensive molecular portraits of human breast tumours.人类乳腺肿瘤的全面分子特征图谱。
Nature. 2012 Oct 4;490(7418):61-70. doi: 10.1038/nature11412. Epub 2012 Sep 23.
10
Molecular biology in breast cancer: intrinsic subtypes and signaling pathways.乳腺癌的分子生物学:内在亚型和信号通路。
Cancer Treat Rev. 2012 Oct;38(6):698-707. doi: 10.1016/j.ctrv.2011.11.005. Epub 2011 Dec 16.

使用充分方向因子模型分析与乳腺癌生存相关的潜在活动。

Using sufficient direction factor model to analyze latent activities associated with breast cancer survival.

作者信息

Baek Seungchul, Ho Yen-Yi, Ma Yanyuan

机构信息

Department of Mathematics and Statistics, University of Maryland Baltimore County, Baltimore, Maryland.

Department of Statistics, University of South Carolina, Columbia, South Carolina.

出版信息

Biometrics. 2020 Dec;76(4):1340-1350. doi: 10.1111/biom.13208. Epub 2020 Jan 6.

DOI:10.1111/biom.13208
PMID:31860141
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7305041/
Abstract

High-dimensional gene expression data often exhibit intricate correlation patterns as the result of coordinated genetic regulation. In practice, however, it is difficult to directly measure these coordinated underlying activities. Analysis of breast cancer survival data with gene expressions motivates us to use a two-stage latent factor approach to estimate these unobserved coordinated biological processes. Compared to existing approaches, our proposed procedure has several unique characteristics. In the first stage, an important distinction is that our procedure incorporates prior biological knowledge about gene-pathway membership into the analysis and explicitly model the effects of genetic pathways on the latent factors. Second, to characterize the molecular heterogeneity of breast cancer, our approach provides estimates specific to each cancer subtype. Finally, our proposed framework incorporates sparsity condition due to the fact that genetic networks are often sparse. In the second stage, we investigate the relationship between latent factor activity levels and survival time with censoring using a general dimension reduction model in the survival analysis context. Combining the factor model and sufficient direction model provides an efficient way of analyzing high-dimensional data and reveals some interesting relations in the breast cancer gene expression data.

摘要

由于基因调控的协同作用,高维基因表达数据常常呈现出复杂的相关模式。然而在实际中,直接测量这些潜在的协同活动是困难的。对具有基因表达的乳腺癌生存数据进行分析,促使我们采用两阶段潜在因子方法来估计这些未观察到的协同生物过程。与现有方法相比,我们提出的方法具有几个独特的特点。在第一阶段,一个重要的区别是我们的方法将关于基因通路成员的先验生物学知识纳入分析,并明确地对遗传通路对潜在因子的影响进行建模。其次,为了刻画乳腺癌的分子异质性,我们的方法提供了针对每种癌症亚型的估计。最后,由于遗传网络通常是稀疏的,我们提出的框架纳入了稀疏条件。在第二阶段,我们在生存分析背景下使用一般的降维模型,研究潜在因子活性水平与带删失的生存时间之间的关系。结合因子模型和充分方向模型提供了一种分析高维数据的有效方法,并揭示了乳腺癌基因表达数据中的一些有趣关系。